Impact of metabolic syndrome components on clinical outcomes in hypertriglyceridemia-induced acute pancreatitis

Figure 1 Associations of obesity with clinical scores and hospitalization characteristics in hypertriglyceridemia-acute pancreatitis. Comparison between patients with and without obesity. A: Age; B: Sex; C: Hospital stays; D: Hospital costs; E: Ranson scores; F: Bedside index of severity in acute pancreatitis scores; G: Modified computed tomography severity index scores. ^aP < 0.05; CNY: China yuan; BISAP: Bedside index of severity in acute pancreatitis; MCTSI: Modified computed tomography severity index.

Figure 2 Associations of hyperglycaemia with clinical scores and hospitalization characteristics in hypertriglyceridemia-acute pancreatitis. Comparison between patients with and without hyperglycaemia. A: Age; B: Sex; C: Hospital stays; D: Hospital costs; E: Ranson scores; F: Bedside index of severity in acute pancreatitis scores; G: Modified computed tomography severity index scores. ^aP < 0.05; CNY: China yuan; BISAP: Bedside Index of Severity in acute pancreatitis; MCTSI: Modified computed tomography severity index.

Figure 3 Associations of hypertension with clinical scores and hospitalization characteristics in hypertriglyceridemia-acute pancreatitis. Comparison between patients with and without hypertension. A: Age; B: Sex; C: Hospital stays; D: Hospital costs; E: Ranson scores; F: Bedside index of severity in acute pancreatitis scores; G: Modified computed tomography severity index scores. ^aP < 0.05; CNY: China yuan; BISAP: Bedside Index of Severity in acute pancreatitis; MCTSI: Modified computed tomography severity index.

Figure 4 Associations of low high-density lipoprotein cholesterol with clinical scores and hospitalization characteristics in hypertriglyceridemia-acute pancreatitis. Comparison between patients with and without low high-density lipoprotein cholesterol. A: Age; B: Sex; C: Hospital stays; D: Hospital costs; E: Ranson scores; F: Bedside index of severity in acute pancreatitis scores; G: Modified computed tomography severity index scores. ^aP < 0.05; CNY: China yuan; HDL-C: High-density lipoprotein cholesterol; BISAP: Bedside Index of Severity in acute pancreatitis; MCTSI: Modified computed tomography severity index.

Figure 5 The additive effect of metabolic syndrome components on adverse clinical outcomes in hypertriglyceridemia-acute pancreatitis. The impact of different numbers of metabolic syndrome components (1-5) on the incidence. A: Pleural effusion; B: Peritoneal effusion; C: Local complications; D: Acute peripancreatic fluid collection; E: Systemic complications; F: Respiratory failure; G: Renal failure; H: Systemic inflammatory response syndrome; I: Acute respiratory distress syndrome; J: Multiple organ dysfunction syndrome; K: Severe acute pancreatitis; L: Intensive care unit admission. APFC: Acute peripancreatic fluid collection; SIRS: Systemic inflammatory response syndrome; ARDS: Acute respiratory distress syndrome; MODS: Multiple organ dysfunction syndrome; SAP: Severe acute pancreatitis; ICU: Intensive care unit.